07-19-2007: Ciba has entered
an exclusive collaboration with biotechnology company
BRAIN AG to develop novel functional
surface effects from renewable raw materials. The goal is
to identify, characterize and synthesize biomolecules that lend
new functionality to surfaces such as plastics, paper, coatings
and home and personal care products. BRAIN brings to the collaboration
a large library of microorganisms, broad expertise in
white biotechnology and proprietary test systems, while Ciba
contributes cutting-edge application and process development
as well as global marketing capability. The resulting biomaterials
will produce novel and improved surface effects, such as
bioprotection, enhanced printability in polymers and moisture
resistance in a variety of materials.
"Biotechnology presents new opportunities for Ciba to bring innovative
functional surface effects to diverse markets, and this collaboration
reflects our commitment to investing in this key future technology,"
says Martin Riediker, Chief Technology Officer at Ciba. In
working to develop biofunctional materials from renewable resources,
we also strengthen our commitment to sustainable manufacturing.
We look forward to expanding our partnership with BRAIN,
with its proven record of leveraging biotechnology for industrial applications,
in this exciting area of research."
Ciba and BRAIN have previously collaborated on using designer
micro-organisms to develop new biotechnological processes for the
sustainable production of existing specialty products. The expanded
partnership will focus on creating new biomaterials with novel functional
surface effects. Ciba will hold exclusive distribution rights for
any resulting products within the field of collaboration.
Watchlist
This is where you can add this news to your personal favourites
Intertek announced the acquisition of Ciba Expert Services' Environmental, Safety, & Testing and Regulatory businesses, including Cantox Health Sciences and Ashuren Health Sciences.
The acquisition substantially strengthens Intertek's scope and depth for regulatory consulting to meet custo ... more
BASF has finalized its plans for the integration of Ciba Holding AG, which it acquired in April 2009. Under the plans, former Ciba businesses are to be integrated into the operating divisions in BASF’s Performance Products segment where their potential can best be realized and developed. Th ... more
Effective July 1, 2009, BASF’s Paper Chemicals operating division, which was established in April, will be headquartered in Basel, Switzerland, together with two associated business units: Coatings & Starch Europe and Wet End Chemicals. In addition, the European business unit for plastic ad ... more
Ciba Specialty Chemicals (SWX: CIBN, NYSE: CSB) is a leading global company dedicated to producing high-value effects for its customers’ products. We strive to be the partner of choice for our customers, offering them innovative products and one-stop expert service. We create effects that ... more
Our production sites, R&D facilities and sales departments are organized in two subsidiaries. Ciba Holding Deutschland GmbH is serving as the parent organization of these subsidiaries. The holding including the Business Support Group supports the entities with administrative, financial and ... more
Ciba is a leading global company dedicated to producing high-value effects for its customers’ products. We create effects that improve the quality of life – adding performance, protection, color and strength to plastics, paper, automobiles, buildings, home and personal care products and muc ... more
More about BRAIN Biotechnology Research And Information Network
Tailor-made specialist micro-organisms directly “feed” on CO2-containing flue gases from lignitefired power stations and even grow at temperatures of 60 degrees centigrade. This is the very promising initial result of a research project run in co-operation by RWE Power and BRAIN AG.
The ele ... more
To convert carbon dioxide into microbial biomass or biomolecules: such is the goal of co-operative research agreed between RWE Power and BRAIN AG. The power generator and the biotech company want to equip micro-organisms” with new enzymes and explore innovative synthesis routes and pathways ... more
BRAIN AG and DSM join forces in the fields of enzyme systems and strain development for the fermentative production of specialty chemicals.
Thanks to DSM’s experience in producing and marketing specialty chemicals and BRAIN AG’s expertise in the fields of technology and microbial resources ... more
BRAIN AG discovers and develops novel technical enzymes for the chemical and life science industries as well as new bioactive substances for the pharmaceutical and cosmetics market. Its EvoSolution® technology platform combines the untapped biodiversity of microorganisms and plants with mod ... more